Evidence map›Paper›PMID 29962950›Full record

ArticleFrontiers in pharmacology2018

UPLC-QTOF/MS

Zhi-Rui Yang, Zi-Hao Wang, Jin-Fa Tang, Yan Yan, Shi-Jun Yue, Wu-Wen Feng, Zheng-Yuan Shi, Xin-Tong Meng, Cheng Peng, Chang-Yun Wang and 2 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Anaphylactic Rare Saponins Separated fromEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  4. Metabolite Profiling of Methanolic Extract ofPharmaceuticals (Basel, Switzerland) · 2021
    Article
  5. Preparation, optimization, andDrug delivery · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhi-Rui YangBeijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Zi-Hao WangBeijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Jin-Fa TangDepartment of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
Yan YanSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China.
Shi-Jun YueBeijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Wu-Wen FengDepartment of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Zheng-Yuan ShiBeijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Xin-Tong MengBeijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Cheng PengDepartment of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Chang-Yun WangKey Laboratory of Marine Drugs (Ministry of Education of China), School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Da-Li MengSchool of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China.
Dan YanBeijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xueshuantong Lyophilized Powder (XST), consisting of a series of saponins extracted from

Indexed as

adverse drug reactionbioassayquality fluctuationUPLC-QTOF/MSEXueshuantong lyophilized powder

Identifiers

PMID29962950
PMCPMC6013573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.